IDEAYA BIOSCIENCES INC (IDYA) Stock Analyst Ratings
USA - NASDAQ:IDYA - US45166A1025 - Common Stock
25.87 USD
-0.05 (-0.19%)
ChartMill assigns a Buy % Consensus number of 85% to IDYA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 45.97. This target is 77.69% above the current price.
IDYA was analyzed by 22 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about IDYA.
In the previous month the buy percentage consensus was at a similar level.
IDYA was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-18 | Guggenheim | Initiate | Buy |
| 2025-09-12 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-09-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-09-09 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-09 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2025-09-08 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-09-04 | JMP Securities | Initiate | Market Outperform |
| 2025-09-04 | Barclays | Initiate | Overweight |
| 2025-09-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-28 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-22 | TD Cowen | Initiate | Buy |
| 2025-07-09 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-26 | Wells Fargo | Initiate | Overweight |
| 2025-05-22 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-14 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2025-01-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-12-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-12-17 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-11-18 | Stephens & Co. | Initiate | Overweight |
| 2024-11-05 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-10-29 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-10-24 | UBS | Initiate | Buy |
| 2024-09-24 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-09-24 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-09-10 | Stifel | Maintains | Buy -> Buy |
| 2024-08-27 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-07 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-07 | RBC Capital | Reiterate | Outperform -> Outperform |